Copyright and Trademark Notice

All materials published or otherwise accessible through the online Research Grant application process, including, but not limited to, text, photographs, images, graphics, illustrations, audio clips, video clips, software and other materials (the “Content”) are protected by copyright, and are owned or controlled by Prostate Cancer Canada (PCC). All applicants shall abide by all additional copyright notices, information and restrictions contained in any Content accessed through the Research Grant application process. 

The Research Grant application process is protected by copyright as a collective work and/or compilation, pursuant to Canadian copyright laws, international conventions, and other copyright laws. Any reproduction, modification, publication, transmission, transfer, sale, distribution, performance, display or exploitation of any of the Content, whether in whole or in part, without the express written permission of PCC is prohibited.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More

Scientists identify DNA signature linked to prostate cancer severity

January 9, 2017 – TORONTO, ON – The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature.
More

Thank You to our Canadian Mo Bros and Sistas!

TORONTO, December 1, 2016 - Prostate Cancer Canada congratulates the more than 500,000 Mo Bros and Mo Sistas worldwide who participated in this year's Movember campaign.
More


Click here for news archive